Evidence map›Paper›PMID 32857678›Full record

ArticleCancer biology & therapy2020

Overexpression of family with sequence similarity 134, member B (FAM134B) in colon cancers and its tumor suppressive properties in vitro.

Katherine Ting-Wei Lee, Farhadul Islam, Jelena Vider, Jeremy Martin, Anna Chruścik, Cu-Tai Lu, Vinod Gopalan, Alfred Kin-Yan Lam

Open access · bronzeAbstract read
In one paragraph

Article in Cancer biology & therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Anti-cancer agents in medicinal chemistry · 2025
    Article
  4. Review
  5. Review
  6. Biosensors, Recent Advances in Determination of BDNF and NfL.Cellular and molecular neurobiology · 2023
    Review
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Katherine Ting-Wei LeeCancer Molecular Pathology, School of Medicine, Griffith University , Gold Coast, Australia.
Farhadul IslamCancer Molecular Pathology, School of Medicine, Griffith University , Gold Coast, Australia.
Jelena ViderSchool of Medical Science, Griffith University , Gold Coast, Australia.
Jeremy MartinCancer Molecular Pathology, School of Medicine, Griffith University , Gold Coast, Australia.
Anna ChruścikCancer Molecular Pathology, School of Medicine, Griffith University , Gold Coast, Australia.
Cu-Tai LuDepartment of Surgery, Gold Coast University Hospital , Gold Coast, Australia.
Vinod GopalanCancer Molecular Pathology, School of Medicine, Griffith University , Gold Coast, Australia.
Alfred Kin-Yan LamCancer Molecular Pathology, School of Medicine, Griffith University , Gold Coast, Australia.
Griffith University · AUGold Coast Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to investigate the overexpression-induced properties of tumor suppressor

Indexed as

ApoptosisCell ProliferationColonic NeoplasmsFemaleGenes, Tumor SuppressorHumansIntracellular Signaling Peptides and ProteinsMaleMembrane ProteinsTransfectionIntracellular Signaling Peptides and ProteinsMembrane ProteinsRETREG1 protein, humancancercoloncolorectalFAM134BMIFmitochondrial functionp53

Identifiers

PMID32857678
PMCPMC7583494
OpenAlexW3081929673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.